DiagnosTear Technologies Inc.DTR.CN
Health Care · Health Care Equipment & Services · CSE · Canada · diagnostear.com
DiagnosTear Technologies Inc., a subsidiary of Israel's BioLight Life Sciences, develops and commercializes point-of-care ophthalmic diagnostics based on its TeaRx™ platform, which analyzes non-invasively collected tear fluid. Its first CE-IVD and Israeli MoH-approved test targets Dry Eye Syndrome (not yet FDA-cleared), with TeaRx™ Red Eye for differential diagnosis of conjunctivitis and keratitis in the pipeline.
Recent news
DiagnosTear Technologies Announces FDA Pre-Submission for TeaRx™ Red Eye Diagnostic Test
DiagnosTear Technologies Inc. Announces Private Placement of Units
Track DTR.CN in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer